Document Detail


Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
MedLine Citation:
PMID:  18249331     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Because infants have relatively more blood loss (mL/kg) than older children during cardiac surgery involving cardiopulmonary bypass (CPB), the authors compared hemostatic activation between infants and older children undergoing cardiac surgery. DESIGN: Observational study. SETTING: University-affiliated children's hospital. PARTICIPANTS: Twenty-eight children (18 infants <1 year and 10 children >1 year) undergoing cardiac surgery with CPB. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Markers of coagulation and fibrinolysis were evaluated at 9 sample points before, during, and after CPB in the 28 children. Infants had greater chest tube output, longer CPB times, and a larger drop in platelet counts during CPB than children. Active tissue plasminogen activator (tPA) increased during CPB in both groups, with infants showing lower levels than children (p < 0.001). In both groups, active plasminogen activator inhibitor type 1 (PAI-1) first decreased during CPB and then increased above baseline postoperatively. Infants had higher PAI-1 than children near the end of CPB (p = 0.01). Thrombin-antithrombin complex levels increased during and after CPB, with infants showing lower levels only during CPB (p = 0.01). D-dimer and prothrombin activation peptide (F1.2) levels increased in a similar pattern for both groups during and after CPB. The length of aortic cross-clamp time and the level of F1.2 after protamine administration correlated significantly and independently with 12-hour chest tube output. CONCLUSIONS: Compared with children, infants had greater blood loss (mL/kg), greater drop in platelets during CPB, lower active tPA, and higher active PAI-1. Cumulative thrombin generation after CPB, indicated by F1.2 levels, correlated with early blood loss.
Authors:
Michael J Eisses; Wayne L Chandler
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2007-08-22
Journal Detail:
Title:  Journal of cardiothoracic and vascular anesthesia     Volume:  22     ISSN:  1532-8422     ISO Abbreviation:  J. Cardiothorac. Vasc. Anesth.     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-02-05     Completed Date:  2008-05-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9110208     Medline TA:  J Cardiothorac Vasc Anesth     Country:  United States    
Other Details:
Languages:  eng     Pagination:  53-9     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, USA. michael.eisses@seattlechildrens.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Age Factors
Blood Coagulation*
Blood Loss, Surgical*
Cardiopulmonary Bypass*
Child
Child, Preschool
Female
Fibrin Fibrinogen Degradation Products / analysis
Fibrinopeptide A / analysis
Humans
Infant
Male
Monitoring, Intraoperative
Plasminogen Activator Inhibitor 1 / analysis
Platelet Count
Thrombin / metabolism
Time Factors
Tissue Plasminogen Activator / blood
Grant Support
ID/Acronym/Agency:
M01-RR-00037/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Fibrin Fibrinogen Degradation Products; 0/Plasminogen Activator Inhibitor 1; 0/fibrin fragment D; 25422-31-5/Fibrinopeptide A; EC 3.4.21.5/Thrombin; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surge...
Next Document:  Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity ...